Pyridinylpiperazin derivatives useful as modulators of dopamine D3 receptors

Details for Australian Patent Application No. 2009296047 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gobbi, Luca; Jaeschke, Georg; Rodriguez Sarmiento, Rosa Maria; Steward, Lucinda

Agent Spruson & Ferguson

Pub. Number AU-A-2009296047

PCT Pub. Number WO2010/034648

Priority 08164898.2 23.09.08 EP

Filing date 15 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/444 (2006.01)

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/034648 Priority application(s): WO2010/034648

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296048-2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as FXR modulators against dyslipidemia and related diseases

2009296045-Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors